# Novartis Gene Therapies Inc. – FDA Inspection, Jan 26, 2024

Source: https://www.keypedia.com/records/fda_inspections/novartis-gene-therapies-inc/ab2c39ea-5177-471e-8597-985d34d47929
Source feed: FDA_Inspections

> FDA inspection 1228634 of Novartis Gene Therapies Inc., January 26, 2024. Classification: Voluntary Action Indicated (VAI). 2 citations under 21 CFR parts 211 and 600.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1228634
- Company Name: Novartis Gene Therapies Inc.
- Inspection Date: 2024-01-26
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Human Cellular, Tissue, and Gene Therapies
- Product Type: Biologics
- Center: Biologics
- Office Name: Center for Biologics Evaluation and Research
- Citation Count: 2

## Related Officers

- [FDA Associated Person](https://www.keypedia.com/people/thai-d-truong/7395c128-0adb-44a1-8831-64673c98e93d)
- [FDA Associated Person](https://www.keypedia.com/people/unnee-ranjan/43f1d07e-4079-4d33-88a9-baf6a5df932c)

Company: https://www.keypedia.com/companies/novartis-gene-therapies-inc/23cc49c0-8794-437d-a2c2-4197479c5fb3

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d
